Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis. (Q53218871)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 June 2011

Language	Label	Description	Also known as
English	Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.	scientific article published on 12 June 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

glomerulonephritis

1 reference

based on heuristic

inferred from title

author name string

Yukiko Kinoshita

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

Shuji Kondo

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

Maki Urushihara

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

Kenichi Suga

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

Sato Matsuura

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

Masanori Takamatsu

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

Maki Shimizu

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

Akira Nishiyama

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

Hiroshi Kawachi

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

Shoji Kagami

10

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

publication date

12 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

Translational Research

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

158

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

235-248

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

Transforming growth factor beta in tissue fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Oxidants in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Cytokines in glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Angiotensin II-induced reactive oxygen species and the kidney

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Mechanisms of angiotensin II signaling on cytoskeleton of podocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Role of integrin-linked kinase in epithelial-mesenchymal transition in crescent formation of experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Mechanisms for the clinical benefits of angiotensin II receptor blockers

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

The role of macrophages in glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Importance of blood pressure control in chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Latent TGF-beta1 protects against crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Nox-2 is a modulator of fibrogenesis in kidney allografts

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.05.003

7 January 2021

Identifiers

10.1016/J.TRSL.2011.05.003

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21925120

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53218871&oldid=1367503981"